Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues-Reference-Cited by-同舟云学术

Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues

Published:2022-12-20 Issue:1 Volume:104 Page:27-50
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Porwit Anna¹^ORCID,Béné Marie C.²^ORCID,Duetz Carolien³,Matarraz Sergio⁴,Oelschlaegel Uta⁵,Westers Theresia M.³,Wagner‐Ballon Orianne⁶⁷^ORCID,Kordasti Shahram⁸,Valent Peter⁹,Preijers Frank¹⁰,Alhan Canan³,Bellos Frauke¹¹,Bettelheim Peter¹²,Burbury Kate¹³,Chapuis Nicolas¹⁴¹⁵^ORCID,Cremers Eline¹⁶,Della Porta Matteo G.¹⁷¹⁸,Dunlop Alan¹⁹,Eidenschink‐Brodersen Lisa²⁰,Font Patricia²¹,Fontenay Michaela¹⁴¹⁵,Hobo Willemijn⁹,Ireland Robin²²,Johansson Ulrika²³,Loken Michael R.²⁰,Ogata Kiyoyuki²⁴,Orfao Alberto⁴,Psarra Katherina²⁵,Saft Leonie²⁶,Subira Dolores²⁷^ORCID,te Marvelde Jeroen²⁸,Wells Denise A.²⁰,van der Velden Vincent H. J.²⁸^ORCID,Kern Wolfgang¹¹,van de Loosdrecht Arjan A.³

Affiliation:

1. Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine Lund University Lund Sweden

2. Hematology Biology Nantes University Hospital, CRCINA Inserm 1232 Nantes France

3. Department of Hematology, Amsterdam UMC VU University Medical Center Cancer Center Amsterdam Amsterdam The Netherlands

4. Cancer Research Center (IBMCC‐USAL/CSIC), Department of Medicine and Cytometry Service Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, University of Salamanca Salamanca Spain

5. Department of Internal Medicine University Hospital Carl‐Gustav‐Carus, TU Dresden Dresden Germany

6. Department of Hematology and Immunology, Assistance Publique‐Hôpitaux de Paris University Hospital Henri Mondor Créteil France

7. Inserm U955 Université Paris‐Est Créteil Créteil France

8. Comprehensive Cancer Centre King's College London London UK

9. Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology Medical University of Vienna Vienna Austria

10. Laboratory of Hematology, Department of Laboratory Medicine Radboud University Medical Center Nijmegen The Netherlands

11. MLL Munich Leukemia Laboratory Munich Germany

12. Department of Hematology Ordensklinikum Linz, Elisabethinen Linz Austria

13. Department of Haematology Peter MacCallum Cancer Centre, & University of Melbourne Melbourne Australia

14. Laboratory of Hematology, Assistance Publique‐Hôpitaux de Paris Centre‐Université de Paris, Cochin Hospital Paris France

15. Institut Cochin, INSERM U1016, CNRS UMR Université de Paris Paris France

16. Division of Hematology, Department of Internal Medicine Maastricht University Medical Center Maastricht The Netherlands

17. IRCCS Humanitas Research Hospital Milan Italy

18. Department of Biomedical Sciences Humanitas University Milan Italy

19. Department of Haemato‐Oncology Royal Marsden Hospital London UK

20. HematoLogics, Inc. Seattle Washington USA

21. Department of Hematology Hospital General Universitario Gregorio Marañon–IiSGM Madrid Spain

22. Department of Haematology and SE‐HMDS King's College Hospital NHS Foundation Trust London UK

23. Laboratory Medicine, SI‐HMDS University Hospitals Bristol and Weston NHS Foundation Trust Bristol UK

24. Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan) Tokyo Japan

25. Department of Immunology – Histocompatibility Evangelismos Hospital Athens Greece

26. Clinical Pathology and Cancer Diagnostics Karolinska University Hospital and Institute Solna Stockholm Sweden

27. Department of Hematology, Flow Cytometry Unit Hospital Universitario de Guadalajara Guadalajara Spain

28. Laboratory Medical Immunology, Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22108

Reference183 articles.

1. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

2. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

3. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes

4. The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

5. Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms;Leukemia;2024-01-16

2. Diagnosis and classification of myelodysplastic syndromes;Blood;2023-12-28

3. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms;Clinics in Laboratory Medicine;2023-12

4. The role of flow cytometry in the classification of myeloid disorders;Die Pathologie;2023-11-22

5. Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes;Blood Advances;2023-08-10